{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:40:26Z","timestamp":1786981226521,"version":"build-2736575974"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,2,21]],"date-time":"2017-02-21T00:00:00Z","timestamp":1487635200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National Natural Science Foundation of China (CN)","award":["81373139"],"award-info":[{"award-number":["81373139"]}]},{"name":"Zhejiang Provincial Medical Scientific Research Foundation","award":["2015KYA206"],"award-info":[{"award-number":["2015KYA206"]}]},{"name":"Zhejiang Provincial Natural Science Foundation of China","award":["LY16H100001"],"award-info":[{"award-number":["LY16H100001"]}]},{"name":"Zhejiang Provincial Public Welfare Technology Application Research Project","award":["2015C37122"],"award-info":[{"award-number":["2015C37122"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s10753-017-0534-4","type":"journal-article","created":{"date-parts":[[2017,2,20]],"date-time":"2017-02-20T20:49:57Z","timestamp":1487623797000},"page":"894-903","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Adenovirus-Mediated Small Interfering RNA Targeting TAK1 Ameliorates Joint Inflammation with Collagen-Induced Arthritis in Mice"],"prefix":"10.1007","volume":"40","author":[{"given":"Xinjing","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongfeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoju","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhidong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanrong","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangwen","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,21]]},"reference":[{"issue":"Suppl 1","key":"534_CR1","first-page":"S4","volume":"65","author":"JY Park","year":"2007","unstructured":"Park, J.Y., and M.H. Pillinger. 2007. Interleukin-6 in the pathogenesis of rheumatoid arthritis. Bulletin of the NYU Hospital for Joint Diseases 65(Suppl 1): S4\u2013S10.","journal-title":"Bulletin of the NYU Hospital for Joint Diseases"},{"key":"534_CR2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/nrrheum.2015.171","volume":"12","author":"IB McInnes","year":"2016","unstructured":"McInnes, I.B., C.D. Buckley, and J.D. Isaacs. 2016. Cytokines in rheumatoid arthritis\u2014shaping the immunological landscape. Nature Reviews. Rheumatology 12: 63\u201368.","journal-title":"Nature Reviews. Rheumatology"},{"key":"534_CR3","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1358\/dnp.1998.11.6.661380","volume":"11","author":"M Odeh","year":"1998","unstructured":"Odeh, M. 1998. Role of cytokines in rheumatoid arthritis. Drug News & Perspectives 11: 331\u2013341.","journal-title":"Drug News & Perspectives"},{"key":"534_CR4","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/ar1810","volume":"7","author":"LH Meyer","year":"2005","unstructured":"Meyer, L.H., and T. Pap. 2005. MAPK signalling in rheumatoid joint destruction: can we unravel the puzzle? Arthritis Research and Therapy 7: 177\u2013178.","journal-title":"Arthritis Research and Therapy"},{"key":"534_CR5","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1046\/j.1462-5822.2001.00148.x","volume":"3","author":"L Neff","year":"2001","unstructured":"Neff, L., M. Zeisel, J. Sibilia, M. Scholler-Guinard, J.P. Klein, and D. Wachsmann. 2001. NF-kappaB and the MAP kinases\/AP-1 pathways are both involved in interleukin-6 and interleukin-8 expression in fibroblast-like synoviocytes stimulated by protein I\/II, a modulin from oral streptococci. Cellular Microbiology 3: 703\u2013712.","journal-title":"Cellular Microbiology"},{"key":"534_CR6","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/rheumatology\/kem297","volume":"47","author":"T Thalhamer","year":"2008","unstructured":"Thalhamer, T., M.A. McGrath, and M.M. Harnett. 2008. MAPKs and their relevance to arthritis and inflammation. Rheumatology (Oxford) 47: 409\u2013414.","journal-title":"Rheumatology (Oxford)"},{"key":"534_CR7","doi-asserted-by":"crossref","first-page":"33080","DOI":"10.1074\/jbc.M807574200","volume":"283","author":"M Inagaki","year":"2008","unstructured":"Inagaki, M., E. Omori, J.Y. Kim, Y. Komatsu, G. Scott, M.K. Ray, et al. 2008. TAK1-binding protein 1, TAB1, mediates osmotic stress-induced TAK1 activation but is dispensable for TAK1-mediated cytokine signaling. Journal of Biological Chemistry 283: 33080\u201333086.","journal-title":"Journal of Biological Chemistry"},{"key":"534_CR8","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1182\/blood-2011-07-369397","volume":"120","author":"D Buglio","year":"2012","unstructured":"Buglio, D., S. Palakurthi, K. Byth, F. Vega, D. Toader, J. Saeh, et al. 2012. Essential role of TAK1 in regulating mantle cell lymphoma survival. Blood 120: 347\u2013355.","journal-title":"Blood"},{"key":"534_CR9","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1046\/j.1523-1755.1999.00665.x","volume":"56","author":"Y Terada","year":"1999","unstructured":"Terada, Y., O. Nakashima, S. Inoshita, M. Kuwahara, S. Sasaki, and F. Marumo. 1999. TGF-beta-activating kinase-1 inhibits cell cycle and expression of cyclin D1 and A in LLC-PK1 cells. Kidney International 56: 1378\u20131390.","journal-title":"Kidney International"},{"key":"534_CR10","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/ni1255","volume":"6","author":"S Sato","year":"2005","unstructured":"Sato, S., H. Sanjo, K. Takeda, J. Ninomiya-Tsuji, M. Yamamoto, T. Kawai, et al. 2005. Essential function for the kinase TAK1 in innate and adaptive immune responses. Nature Immunology 6: 1087\u20131095.","journal-title":"Nature Immunology"},{"key":"534_CR11","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.cell.2011.12.033","volume":"148","author":"A Singh","year":"2012","unstructured":"Singh, A., M.F. Sweeney, M. Yu, A. Burger, P. Greninger, C. Benes, et al. 2012. TAK1 inhibition promotes apoptosis in KRAS-dependent colon cancers. Cell 148: 639\u2013650.","journal-title":"Cell"},{"key":"534_CR12","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/ni1355","volume":"7","author":"YY Wan","year":"2006","unstructured":"Wan, Y.Y., H. Chi, M. Xie, M.D. Schneider, and R.A. Flavell. 2006. The kinase TAK1 integrates antigen and cytokine receptor signaling for T cell development, survival and function. Nature Immunology 7: 851\u2013858.","journal-title":"Nature Immunology"},{"key":"534_CR13","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.4161\/cc.5.24.3558","volume":"5","author":"JR Delaney","year":"2006","unstructured":"Delaney, J.R., and M. Mlodzik. 2006. TGF-beta activated kinase-1: new insights into the diverse roles of TAK1 in development and immunity. Cell Cycle 5: 2852\u20132855.","journal-title":"Cell Cycle"},{"key":"534_CR14","doi-asserted-by":"crossref","first-page":"E343","DOI":"10.1073\/pnas.1115635109","volume":"109","author":"Y Wang","year":"2012","unstructured":"Wang, Y., G. Huang, P. Vogel, G. Neale, B. Reizis, and H. Chi. 2012. Transforming growth factor beta-activated kinase 1 (TAK1)-dependent checkpoint in the survival of dendritic cells promotes immune homeostasis and function. Proceedings of the National Academy of Sciences of the United States of America 109: E343\u2013E352.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"534_CR15","doi-asserted-by":"crossref","first-page":"e31550","DOI":"10.1371\/journal.pone.0031550","volume":"7","author":"C Eftychi","year":"2012","unstructured":"Eftychi, C., N. Karagianni, M. Alexiou, M. Apostolaki, and G. Kollias. 2012. Myeloid TAKI [corrected] acts as a negative regulator of the LPS response and mediates resistance to endotoxemia. PloS One 7: e31550.","journal-title":"PloS One"},{"key":"534_CR16","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.4049\/jimmunol.172.3.1612","volume":"172","author":"DR Hammaker","year":"2004","unstructured":"Hammaker, D.R., D.L. Boyle, M. Chabaud-Riou, and G.S. Firestein. 2004. Regulation of c-Jun N-terminal kinase by MEKK-2 and mitogen-activated protein kinase kinase kinases in rheumatoid arthritis. Journal of Immunology 172: 1612\u20131618.","journal-title":"Journal of Immunology"},{"key":"534_CR17","doi-asserted-by":"crossref","first-page":"R57","DOI":"10.1186\/ar2215","volume":"9","author":"DR Hammaker","year":"2007","unstructured":"Hammaker, D.R., D.L. Boyle, T. Inoue, and G.S. Firestein. 2007. Regulation of the JNK pathway by TGF-beta activated kinase 1 in rheumatoid arthritis synoviocytes. Arthritis Research and Therapy 9: R57.","journal-title":"Arthritis Research and Therapy"},{"key":"534_CR18","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1093\/rheumatology\/ker021","volume":"50","author":"J Geurts","year":"2011","unstructured":"Geurts, J., B.T. van den Brand, A. Wolf, S. Abdollahi-Roodsaz, O.J. Arntz, M. Kracht, et al. 2011. Toll-like receptor 4 signalling is specifically TGF-beta-activated kinase 1 independent in synovial fibroblasts. Rheumatology (Oxford) 50: 1216\u20131225.","journal-title":"Rheumatology (Oxford)"},{"key":"534_CR19","unstructured":"Fechtner, S., Fox, D.A., and Ahmed, S. Transforming growth factor beta activated kinase 1: A potential therapeutic target for rheumatic diseases. Rheumatology (Oxford)."},{"key":"534_CR20","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.bbrc.2005.08.198","volume":"336","author":"A Inoue","year":"2005","unstructured":"Inoue, A., K.A. Takahashi, O. Mazda, R. Terauchi, Y. Arai, T. Kishida, et al. 2005. Electro-transfer of small interfering RNA ameliorated arthritis in rats. Biochemical and Biophysical Research Communications 336: 903\u2013908.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"534_CR21","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1002\/art.23660","volume":"58","author":"M Khoury","year":"2008","unstructured":"Khoury, M., V. Escriou, G. Courties, A. Galy, R. Yao, C. Largeau, et al. 2008. Efficient suppression of murine arthritis by combined anticytokine small interfering RNA lipoplexes. Arthritis and Rheumatism 58: 2356\u20132367.","journal-title":"Arthritis and Rheumatism"},{"key":"534_CR22","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1002\/art.21876","volume":"54","author":"M Khoury","year":"2006","unstructured":"Khoury, M., P. Louis-Plence, V. Escriou, D. Noel, C. Largeau, C. Cantos, et al. 2006. Efficient new cationic liposome formulation for systemic delivery of small interfering RNA silencing tumor necrosis factor alpha in experimental arthritis. Arthritis and Rheumatism 54: 1867\u20131877.","journal-title":"Arthritis and Rheumatism"},{"key":"534_CR23","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1002\/art.20975","volume":"52","author":"RM Schiffelers","year":"2005","unstructured":"Schiffelers, R.M., J. Xu, G. Storm, M.C. Woodle, and P.V. Scaria. 2005. Effects of treatment with small interfering RNA on joint inflammation in mice with collagen-induced arthritis. Arthritis and Rheumatism 52: 1314\u20131318.","journal-title":"Arthritis and Rheumatism"},{"key":"534_CR24","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s10753-010-9250-z","volume":"34","author":"X Luo","year":"2011","unstructured":"Luo, X., X. Zuo, X. Mo, Y. Zhou, and X. Xiao. 2011. Treatment with recombinant Hsp72 suppresses collagen-induced arthritis in mice. Inflammation 34: 432\u2013439.","journal-title":"Inflammation"},{"key":"534_CR25","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K.J., and T.D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402\u2013408.","journal-title":"Methods"},{"key":"534_CR26","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nri2094","volume":"7","author":"IB McInnes","year":"2007","unstructured":"McInnes, I.B., and G. Schett. 2007. Cytokines in the pathogenesis of rheumatoid arthritis. Nature Reviews Immunology 7: 429\u2013442.","journal-title":"Nature Reviews Immunology"},{"key":"534_CR27","first-page":"109","volume":"15","author":"IM El-Kady","year":"2008","unstructured":"El-Kady, I.M., and S.A. El-Masry. 2008. Pro-inflammatory and anti-inflammatory cytokines profile in rheumatoid arthritis patients. The Egyptian Journal of Immunology 15: 109\u2013114.","journal-title":"The Egyptian Journal of Immunology"},{"key":"534_CR28","first-page":"545493","volume":"2014","author":"A Burska","year":"2014","unstructured":"Burska, A., M. Boissinot, and F. Ponchel. 2014. Cytokines as biomarkers in rheumatoid arthritis. Mediators of Inflammation 2014: 545493.","journal-title":"Mediators of Inflammation"},{"key":"534_CR29","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/ncprheum0683","volume":"4","author":"WB Berg van den","year":"2008","unstructured":"van den Berg, W.B. 2008. Cytokines and joint erosion in arthritis. Nature Clinical Practice Rheumatology 4: 58\u201359.","journal-title":"Nature Clinical Practice Rheumatology"},{"key":"534_CR30","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1126\/science.1072682","volume":"298","author":"GL Johnson","year":"2002","unstructured":"Johnson, G.L., and R. Lapadat. 2002. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298: 1911\u20131912.","journal-title":"Science"},{"issue":"Suppl 2","key":"534_CR31","doi-asserted-by":"crossref","first-page":"ii86","DOI":"10.1136\/ard.62.suppl_2.ii86","volume":"62","author":"D Hammaker","year":"2003","unstructured":"Hammaker, D., S. Sweeney, and G.S. Firestein. 2003. Signal transduction networks in rheumatoid arthritis. Annals of the Rheumatic Diseases 62(Suppl 2): ii86\u2013ii89.","journal-title":"Annals of the Rheumatic Diseases"},{"key":"534_CR32","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/1756-185X.12293","volume":"17","author":"LA MacFarlane","year":"2014","unstructured":"MacFarlane, L.A., and D.J. Todd. 2014. Kinase inhibitors: the next generation of therapies in the treatment of rheumatoid arthritis. International Journal of Rheumatic Diseases 17: 359\u2013368.","journal-title":"International Journal of Rheumatic Diseases"},{"key":"534_CR33","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nrd2829","volume":"8","author":"M Gaestel","year":"2009","unstructured":"Gaestel, M., A. Kotlyarov, and M. Kracht. 2009. Targeting innate immunity protein kinase signalling in inflammation. Nature Reviews Drug Discovery 8: 480\u2013499.","journal-title":"Nature Reviews Drug Discovery"},{"key":"534_CR34","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ceb.2009.01.015","volume":"21","author":"P Cohen","year":"2009","unstructured":"Cohen, P. 2009. Targeting protein kinases for the development of anti-inflammatory drugs. Current Opinion in Cell Biology 21: 317\u2013324.","journal-title":"Current Opinion in Cell Biology"},{"key":"534_CR35","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/ncb1823","volume":"11","author":"Q Liu","year":"2009","unstructured":"Liu, Q., J.C. Busby, and J.D. Molkentin. 2009. Interaction between TAK1-TAB1-TAB2 and RCAN1-calcineurin defines a signalling nodal control point. Nature Cell Biology 11: 154\u2013161.","journal-title":"Nature Cell Biology"},{"key":"534_CR36","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1172\/JCI32639","volume":"118","author":"S Abdollahi-Roodsaz","year":"2008","unstructured":"Abdollahi-Roodsaz, S., L.A. Joosten, M.I. Koenders, I. Devesa, M.F. Roelofs, T.R. Radstake, et al. 2008. Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis. Journal of Clinical Investigation 118: 205\u2013216.","journal-title":"Journal of Clinical Investigation"},{"key":"534_CR37","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.bbrc.2009.06.150","volume":"388","author":"S Nakagawa","year":"2009","unstructured":"Nakagawa, S., Y. Arai, H. Mori, Y. Matsushita, T. Kubo, and T. Nakanishi. 2009. Small interfering RNA targeting CD81 ameliorated arthritis in rats. Biochemical and Biophysical Research Communications 388: 467\u2013472.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"534_CR38","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3109\/s10165-008-0131-3","volume":"19","author":"A Inoue","year":"2009","unstructured":"Inoue, A., K.A. Takahashi, O. Mazda, Y. Arai, M. Saito, T. Kishida, et al. 2009. Comparison of anti-rheumatic effects of local RNAi-based therapy in collagen induced arthritis rats using various cytokine genes as molecular targets. Modern Rheumatology 19: 125\u2013133.","journal-title":"Modern Rheumatology"},{"key":"534_CR39","first-page":"523","volume":"252","author":"C Shen","year":"2004","unstructured":"Shen, C., and S.N. Reske. 2004. Adenovirus-delivered siRNA. Methods in Molecular Biology 252: 523\u2013532.","journal-title":"Methods in Molecular Biology"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-017-0534-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10753-017-0534-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-017-0534-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T10:43:12Z","timestamp":1749984192000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10753-017-0534-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,21]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["534"],"URL":"https:\/\/doi.org\/10.1007\/s10753-017-0534-4","relation":{},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"value":"0360-3997","type":"print"},{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,21]]}}}